Change currency
Mozambique Pharmaceuticals and Healthcare Report Q2 (BMI08204)
2013BMI View: Strong real GDP growth and rich natural resources ensure that Mozambique remains a popular investment choice in the region. The country's pharmaceutical and healthcare sectors certainly benefit from the...		Feb 2013£755€894$1,175
The Pharmaceutical Market - Mozambique (ESP00854)
Summary BMI's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context....		Jan 2013£810€959$1,261
The Pharmaceutical Market: Mozambique (ESP00834)
Summary BMI's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context....		Jan 2013£810€959$1,261
Mozambique Pharmaceuticals and Healthcare Report Q1 (BMI08804)
2013BMI View: Mozambique relies on drug imports to supply the majority of its domestic demand, but since July 2012, has started limited national production of antiretrovirals at the state-owned Sociedade...		Jan 2013£755€894$1,175
Mozambique Pharmaceuticals and Healthcare Report Q3 (BMI08427)
2012BMI View: Mozambique has one of Africa's most robust economies, with strong GDP growth and a positive macroeconomic outlook, but there is a sense that the country's healthcare and pharmaceutical...		May 2012£755€894$1,175
Healthcare Overview of Mozambique (FRS02134)
Healthcare Overview in Mozambique provides an overview of the healthcare industry, and pharmaceuticals, in Mozambique. The research service analyses Mozambique's healthcare environment in great depth, focusing on health structure, infrastructure...		Dec 2010£5,140€6,088$8,000